StockData
Vor Biopharma Inc. logo

Vor Biopharma Inc. (VOR) stock

VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 5/30
$18.52+0.69 (+3.87%)

Close on Nov 19, 2026Market cap $1.14BP/E –Yield –

Vor Biopharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Vor Biopharma

Vor Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vor Biopharma figures

See a number that looks wrong?